RESPONSEDX: MELANOMA

Welcome to the Brand page for “RESPONSEDX: MELANOMA”, which is offered here for Response dx: melanoma;providing medical diagnostic testing services for diagnostic and prognostic purposes; and providing medical information;melanoma;medical research; scientific research and development, medical and scientific research consulting; drug discovery analysis services; pharmaceutical drug development analysis services; diagnostic testing services, providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; providing scientific research information in the field of pharmaceuticals and clinical trials; providing an on-line computer database for others in the fields of medicine development, pharmacogenomics in the nature of scientific research in the field of genetics, scientific research information in the field of cancer diagnosis, scientific research information in the field of clinical trial design and scientific research information in the field of biotechnology; product development services for others in the biomedical, genomics, pharmacogenomics, diagnostic, clinical trial design and biotechnology fields;.

Its status is currently believed to be active. Its class is unavailable. “RESPONSEDX: MELANOMA” is believed to be currently owned by “CANCER GENETICS, INC.”